News & Updates
Filter by Specialty:
Trial of two tenofovir-containing regimens for HIV/HBV co-infection: Insights from ALLIANCE
The triplet combination of bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) is as good as dolutegravir + emtricitabine/tenofovir disoproxil fumarate (DTG+F/TDF) in terms of efficacy for HIV control but results in better hepatitis B virus (HBV) outcomes in patients with HIV/HBV co-infection, according to results of the phase III ALLIANCE trial presented at IAS 2022.
Trial of two tenofovir-containing regimens for HIV/HBV co-infection: Insights from ALLIANCE
11 Sep 2024
Prednisone better than anakinra-zinc combo for severe alcohol-associated hepatitis
Use of prednisone in patients with severe alcohol-associated hepatitis (SAH) results in significantly better overall and transplant-free survival at 90 days and a lower incidence of acute kidney injury (AKI) when compared with the use of anakinra plus zinc, results of a study have shown.
Prednisone better than anakinra-zinc combo for severe alcohol-associated hepatitis
18 May 2024
HCV cure possible in people who inject drugs despite poor treatment adherence
People who inject drugs (PWID) with low adherence to sofosbuvir/velpatasvir can still be cured of hepatitis C virus (HCV) infection, suggests a study.
